These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

108 related articles for article (PubMed ID: 8896670)

  • 1. Relevance of the trough-to-peak ratio to the 24 h blood pressure load.
    White WB
    Am J Hypertens; 1996 Oct; 9(10 Pt 2):91S-96S; discussion 108S-109S. PubMed ID: 8896670
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Twenty-four-hour blood pressure load as a surrogate end-point in assessing antihypertensive therapy.
    White WB; Lund-Johansen P; Omvik P
    J Hypertens Suppl; 1993 Jun; 11(4):S75-80. PubMed ID: 8377035
    [TBL] [Abstract][Full Text] [Related]  

  • 3. What are the approaches for evaluating antihypertensive treatment by 24 h ambulatory blood pressure monitoring?
    Neutel JM; Smith DH; Weber MA
    Blood Press Monit; 1999; 4 Suppl 2():S23-8. PubMed ID: 10822419
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Trough-to-peak versus surface ratio in the assessment of antihypertensive agents. APTH Investigators. Ambulatory Blood Pressure and Treatment of Hypertension.
    Bieniaszewski L; Staessen JA; Byttebier G; De Leeuw P; Van Hedent T; Fagard R
    Blood Press; 1995 Nov; 4(6):350-7. PubMed ID: 8746602
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Practical relevance of the 24-hour trough: peak ratio of antihypertensive drugs.
    Zannad F
    J Hypertens Suppl; 1995 Aug; 13(2):S109-12. PubMed ID: 8576780
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The use of Fourier analysis in the calculation of trough to peak ratio from ambulatory blood pressure measurements.
    Diamant M; Idema RN; Vincent HH
    J Hum Hypertens; 1998 Jan; 12(1):61-7. PubMed ID: 9482136
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Blood pressure reduction and end-organ damage in hypertension.
    Mancia G; Frattola A; Groppelli A; Omboni S; Parati G; Ulian L; Villani A
    J Hypertens Suppl; 1994 Nov; 12(8):S35-41; discussion S41-2. PubMed ID: 7707154
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Methodology to determine duration of action for antihypertensive drugs.
    Lefebvre J; Poirier L; Lacourcière Y
    Ann Pharmacother; 2002 May; 36(5):874-81. PubMed ID: 11978167
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Efficacy and safety of fosinopril/hydrochlorothiazide combinations on ambulatory blood pressure profiles in hypertension. Fosinopril/Hydrochlorothiazide Investigators.
    Guthrie R; Reggi DR; Plesher MM; Saini RK; Battikha JP
    Am J Hypertens; 1996 Apr; 9(4 Pt 1):306-11. PubMed ID: 8722432
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Problems in the evaluation of antihypertensive therapy using the trough/peak ratio.
    Prattichizzo FA; Galetta F; Simonetti I
    Cardiovasc Drugs Ther; 1997 Jul; 11(3):459-63. PubMed ID: 9310274
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Twenty-four-hour ambulatory blood pressure evaluation of antihypertensive agents.
    Zanchetti A
    J Hypertens Suppl; 1997 Dec; 15(7):S21-5. PubMed ID: 9532517
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Blood pressure load and target organ effects in patients with essential hypertension.
    White WB
    J Hypertens Suppl; 1991 Dec; 9(8):S39-41. PubMed ID: 1839036
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Blood pressure variability: clinical implications and effects of antihypertensive treatment.
    Parati G; Ravogli A; Frattola A; Groppelli A; Ulian L; Santucciu C; Mancia G
    J Hypertens Suppl; 1994 Jul; 12(5):S35-40. PubMed ID: 7965285
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Analysis of ambulatory blood pressure data in antihypertensive drug trials.
    White WB
    J Hypertens Suppl; 1991 Jan; 9(1):S27-32. PubMed ID: 2040903
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Arterial hypertension difficult to control in the elderly patient. The significance of the "white coat effect"].
    Amado P; Vasconcelos N; Santos I; Almeida L; Nazaré J; Carmona J
    Rev Port Cardiol; 1999 Oct; 18(10):897-906. PubMed ID: 10590654
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Ambulatory versus clinic blood pressure for the assessment of anti hypertensive efficacy in clinical trials: insights from the Val-Syst Study.
    Palatini P; Dorigatti F; Mugellini A; Spagnuolo V; Varì N; Ferrara R; Bertocchi F
    Clin Ther; 2004 Sep; 26(9):1436-45. PubMed ID: 15531006
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Trough and peak effects of a single daily dose of nifedipine gastrointestinal therapeutic system (GITS) as assessed by ambulatory blood pressure monitoring. Italian Nifedipine GITS Study Group.
    Zanchetti A
    J Hypertens Suppl; 1994 Jul; 12(5):S23-7. PubMed ID: 7965282
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Sleep-time blood pressure: prognostic value and relevance as a therapeutic target for cardiovascular risk reduction.
    Hermida RC; Ayala DE; Fernández JR; Mojón A
    Chronobiol Int; 2013 Mar; 30(1-2):68-86. PubMed ID: 23181592
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Blunted sleep-time relative blood pressure decline increases cardiovascular risk independent of blood pressure level--the "normotensive non-dipper" paradox.
    Hermida RC; Ayala DE; Mojón A; Fernández JR
    Chronobiol Int; 2013 Mar; 30(1-2):87-98. PubMed ID: 23039824
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Effects of the angiotensin II receptor blockers telmisartan versus valsartan on the circadian variation of blood pressure: impact on the early morning period.
    White WB; Lacourciere Y; Davidai G
    Am J Hypertens; 2004 Apr; 17(4):347-53. PubMed ID: 15062889
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.